Indivior Pharmaceuticals, Inc.
NASDAQIndivior Pharmaceuticals enters the late-May period with a notable gap opening up between price and short sentiment — the stock has rallied 13% over the past month while shorts are quietly trimming, creating a setup that looks less contested than it did just weeks ago. Short sellers have been stepping back consistently. SI as a percentage of the free float has dropped from a recent…
Snapshot as of 22 Jun 2026
Indivior Pharmaceuticals enters the late-May period with a notable gap opening up between price and short sentiment — the stock has rallied 13% over the past month while shorts are quietly trimming, creating a setup…
INDV delivered a sharp Q1 2026 earnings beat today, setting up an unusually charged week-end for a stock that shorts have been quietly building into. Q1 adjusted EPS came in at $0.96, versus a Street estimate of $0.66.…
INDV enters its April 30 earnings release with momentum firmly behind it — but short sellers are quietly building positions even as the stock climbs. The price action tells an optimistic story. INDV has gained 18% over…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INDV — free to start on ORTEX.
Sign up for free →Open INDV on ORTEX